Skip to main content

Month: August 2020

OpGen Co-Markets COVID-19 Antibody Test Kit

GAITHERSBURG, Md., Aug. 09, 2020 (GLOBE NEWSWIRE) — As disclosed in OpGen, Inc.’s (NASDAQ: OPGN) (“OpGen” or “the Company”) July 13, 2020 press release, we have commenced marketing and promotion, on a non-exclusive basis, of certain products offered by Menarini Silicon Biosystems (MSB) to infectious disease healthcare providers and researchers.  As part of the co-promotion relationship, OpGen is marketing and promoting the CELLSEARCH system, CELLSEARCH CEC kit, and certain COVID-19 related products that are sold and distributed by MSB on a non-exclusive basis.  OpGen is authorized to market and promote such products in the United States, Canada, and Mexico under a strategic co-promotion agreement entered into by OpGen and MSB.  As described in our tweet on August 7, 2020, the COVID-19 related products include an IgG/IgM Rapid Test...

Continue reading

Aino Health AB (publ): KALLELSE TILL EXTRA BOLAGSSTÄMMA I AINO HEALTH AB (PUBL)

Aktieägarna i Aino Health (publ), org.nr 559063-5073 (”Bolaget”) kallas härmed till extra bolagsstämma onsdagen den 9 september 2020 i Stockholm.Med anledning av Coronapandemin (Covid-19) kommer den extra bolagsstämman att genomföras endast genom poströstning. Detta betyder att aktieägarna i Bolaget inte har rätt att närvara vid stämman, varken personligen eller genom ombud. Istället har aktieägarna rätt att utöva sin rösträtt per post genom att rösta i förväg enligt instruktionerna i denna kallelse. Rätt att delta vid stämmanPå grund av Coronapandemin och för att säkerställa aktieägares, anställdas och andra intressenters hälsa och säkerhet har styrelsen för Bolaget beslutat att aktieägarna inte ska ha rätt att närvara vid stämman, varken personligen eller genom ombud, och att den som inte är aktieägare inte ska ha rätt att närvara i...

Continue reading

Aino Health AB (publ): Aino Health decides on a fully secured rights issue of shares of approximately SEK 15.9 million

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SWITZERLAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL, BE SUBJECT TO LEGAL RESTRICTIONS OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES.The Board of Directors of Aino Health AB (publ) (“Aino Health” or the “Company”) has, subject to approval at the Extraordinary General Meeting on 9 September 2020, decided to carry out a rights issue of a maximum of 10,623,319 shares (the “Rights issue”). The subscription price per share is SEK 1.50, whereby Aino Health upon full subscription in the Rights issue receives approximately SEK 15.9 million before issue costs. For every (1) existing share on the...

Continue reading

Aino Health AB (publ): Aino Health beslutar om en fullt säkerställd företrädesemission av aktier om cirka 15,9 MSEK

EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AUSTRALIEN, KANADA, NYA ZEELAND, HONGKONG, JAPAN, SCHWEIZ, SINGAPORE, SYDAFRIKA, ELLER I NÅGON ANNAN JURISDIKTION DÄR OFFENTLIGGÖRANDET, PUBLICERINGEN ELLER DISTRIBUTIONEN AV DETTA PRESSMEDDELANDE SKULLE VARA OLAGLIG, VARA FÖREMÅL FÖR LEGALA RESTRIKTIONER ELLER SKULLE KRÄVA REGISTRERING ELLER ANDRA ÅTGÄRDER.Styrelsen för Aino Health AB (publ) (”Aino Health” eller ”Bolaget”) har, förutsatt godkännande på extra bolagsstämman den 9 september 2020, beslutat att genomföra en företrädesemission av högst 10 623 319 aktier (”Företrädesemissionen”). Teckningskursen per aktie är 1,50 SEK, varigenom Aino Health vid full teckning i Företrädesemissionen erhåller cirka 15,9 MSEK före emissionskostnader. För varje (1) befintlig aktie på avstämningsdagen...

Continue reading

Monarch Technologies, Inc. Announces New Partnership with Canna Group Consulting LLC

Monarch Technologies, Inc. (Fintech), a fully licensed Money Transmittal Service Provider, announced today that it has partnered with an industry leader and pioneer Sami Spiezio, Founder/President of Canna Group Consulting LLC Merchant Group, a consulting group that represents independently owned acquisitions and payments offices across the country. Cannabis Banking Solutions Currently, Monarch Technologies is a Fintech Banking Platform, serving businesses as well as City and Governmental Agencies/Regulatory compliance entities. Monarch was built after years of industry research from the state, city and governmental agencies that were frustrated with lack of compliance and thousands of past due tax payments.“We are proud to add Canna Group Consulting LLC to our network as a trusted and valued business partner,” said Christian Fea, Fintech...

Continue reading

Redwood Capital Management Limited: Nasdaq Composite fell short but remained at 11,000, Gold dropped

Nasdaq Composite fell rapidly on today’s session after tech giants such as Amazon, Netflix, Microsoft and Apple dipped simultaneously. Microsoft and Amazon are down around 1.8%. Neflix dipped by 2.8% while Apple loss at least 2.3% which contributed on Nasdaq dropped. The remaining major indices remained positive though. The Dow gained around 40 points while S&P 500 rise a bit with 2.1 points. Gold index and oil prices loss a bit but treasuries are up, while currencies are rallied mixed. Here are the main movements on the Global Stock Market; Stocks – S&P 500 increased a bit with 2.1 points or 0.06% change to 3,351.26.– The Dow Jones Industrial Average has 46.36 points or 0.17% advanced to 27,433.34.– Nasdaq Composite is down with -97.09 points or -0.87% to 11,010.98.– The Stoxx Europe 600 Index rose 0.3%.–...

Continue reading

伊利诺伊州威尔梅特、威斯康星州贝洛伊特和德克萨斯州安格尔顿

UTRECHT (Pays-Bas), et CAMBRIDGE, Massachusetts (États-Unis), 08 août 2020 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq : MRUS), société d’oncologie de stade clinique qui développe des anticorps innovants et multispécifiques pleine longueur (Biclonics® et Triclonics™), a annoncé aujourd’hui que Bill Lundberg, M.D., président-directeur général, présenterait une vue d’ensemble de la société lors de la Wedbush PacGrow Healthcare Conference 2020 le mercredi 12 août 2020 à 10 h 20 HNE.Une diffusion en direct de la présentation sera disponible sur la page consacrée aux investisseurs du site Web de la Société, http://www.merus.nl. Une présentation archivée sera disponible sur le site Web de Merus pendant une durée limitée.À propos de MerusMerus est une entreprise d’oncologie de stade clinique qui développe des traitements...

Continue reading

Merus präsentiert auf der Wedbush PacGrow Healthcare Conference 2020

UTRECHT (Niederlande) und CAMBRIDGE, Massachusetts (USA), Aug. 08, 2020 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq:MRUS), ein Unternehmen im Bereich der klinischen Immunonkologie, das innovative bispezifische Antikörpertherapeutika (Biclonics® und Triclonics™) entwickelt, gab heute bekannt, das Dr. Bill Lundberg, President und Chief Executive Officer, am Mittwoch, dem 12. August 2020 um 10:20 ET (Ostküstenzeit) im Rahmen der Wedbush PacGrow Healthcare Conference 2020 einen Unternehmensüberblick präsentieren wird.Ein Live-Webcast der Präsentation wird auf der Seite für Anleger auf der Website des Unternehmens, http://www.merus.nl, verfügbar sein. Eine archivierte Aufzeichnung wird für begrenzte Zeit auf der Website von Merus zur Verfügung stehen.Über MerusMerus ist ein Unternehmen im Bereich der klinischen Immunonkologie, das unter der...

Continue reading

US Capital Global Increases Its Presence in London with New Office Led by Managing Director Roger Al

Brighton, Brighton and Hove, United Kingdom., August 8, 2020 — US Capital Global is pleased to announce its increased presence in London and the appointment of Roger Allen as Managing Director of the firm’s new London Office, located in the heart of the City. Headquartered in San Francisco, US Capital Global operates worldwide with a strong presence in San Francisco, Las Vegas, and London. The group provides sophisticated debt, equity, and investment products to middle market companies and investors, using the latest FinTech and RegTech innovation. Regulatory hosting and compliance services in the UK are provided for the group by Strata Global Limited. With close to 40 years’ experience within the financial markets, including nine years in asset management, Mr. Allen leads US Capital Global’s London Office with a strong background...

Continue reading

Synergy Capital AM: Tech Giants pushed Nasdaq Composite to another all-time high above11,000

Tech giants such as Facebook, Apple, Google’s sister company Alphabet, Netflix and Microsoft has pushed Nasdaq Composite surge big time on today’s session marking another record high advancing from 10,000 to 11,000 for the first time. Netflix and Alphabet shares both ended more than 1% higher while Facebook ended the day up 6.5%. Apple shares surge 3.5% while Microsoft increased by 1.6%. The three major indices marked its fourth day winning streak just for this week, deleting the coronavirus anxiety on most investors. Gold remained stable above $2,000 market price while oil prices and treasuries are down. Here are the main movements in the Global Stock Market this Thursday; Stocks – The Dow Jones Industrial Average ended higher with 185.46 points or 0.68% ending its price to 27,386.98.– S&P 500 increased a bit too with...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.